| Literature DB >> 22726361 |
Kristin M Huntoon1, Colin J McCluney, Elizabeth A Wiley, Christopher A Scannell, Richard Bruno, Matthew J Stull.
Abstract
BACKGROUND: Advocacy is increasingly being recognized as a core element of medical professionalism and efforts are underway to incorporate advocacy training into graduate and undergraduate medical school curricula. While limited data exist to quantify physician attitudes toward advocacy, even less has been done to assess the knowledge, skills, and attitudes of future physicians. The purpose of this study was to assess students' experiences and attitudes toward legislative advocacy, cutting out using a convience sample.Entities:
Mesh:
Year: 2012 PMID: 22726361 PMCID: PMC3418180 DOI: 10.1186/1472-6920-12-47
Source DB: PubMed Journal: BMC Med Educ ISSN: 1472-6920 Impact factor: 2.463
Demographics of survey respondents
| Primary Survey | 122 |
| Secondary Survey (response rate) | 50 (46.3%) |
| Female | 29 (58.0%) |
| Male | 20 (40.0%) |
| Other | 1 (2.0%) |
| Pre-medical school | 16 (32.0%) |
| Medical school, pre-clinical | 20 (40.0%) |
| MS1 | 8 (16.0%) |
| MS2 | 12 (24.0%) |
| Medical school, clinical | 13 (26.0%) |
| MS3 | 9 (18.0%) |
| MS4 | 4 (8.0%) |
| M.D./Ph.D. training | 1 (2.0%) |
| Health Care for All | 28 (56.0%) |
| Student Debt | 10 (20.0%) |
| Global Health | 7 (14.0%) |
| LGBT | 5 (10.0%) |
| No prior experience | 19 (38.0%) |
| At least one prior experience | 31 (62.0%) |
*Freeform response
†Participants responded to the prompt: “Year of Training (select one)”.
‡Participants responded to the prompt: “What topic will you be lobbying on (select one)?”.
§Participants responded to the prompt: “What type of contact have you had with a legislator or staffer prior to today’s visits (check all that apply)?” If the response was anything other than “None”, participants were said to have had at least one prior experience.
Pre-and post-advocacy mean Likert score responses to survey statements
| | | | | |
| I understand the major provisions of the recently enacted health care reform legislation (Patient Protection and Affordable Care Act). | 3.60 | 3.90 | +0.30 | 0.03 |
| My medical school curriculum has provided me with sufficient health legislative advocacy training. | 2.02 | 1.99 | −0.03 | 0.89 |
| I can describe how public policy affects the health of populations that I serve. | 3.60 | 4.07 | +0.47 | 0.01 |
| I can identify the opportunities available for physicians-in-training to function as health advocates. | 3.24 | 3.82 | +0.58 | <0.001 |
| | | | | |
| I am able to effectively communicate my position to my legislators and/or their staffers. | 3.42 | 3.99 | +0.57 | <0.001 |
| I know what to expect when I meet with legislators and their staffers. | 3.18 | 3.68 | +0.50 | <0.001 |
| | | | | |
| As a physician-in-training, I believe I can influence policy. | 4.16 | 4.20 | +0.04 | 0.73 |
| As a physician-in-training, I believe it is important to contact my legislators about issues important to my future patients. | 4.50 | 4.64 | +0.14 | 0.13 |
| As a physician-in-training, I believe it is important to contact my legislators about issues that will affect the way I will practice medicine. | 4.26 | 4.66 | +0.40 | 0.03 |
| Participating in the legislative process is a professional responsibility of physicians | 3.80 | 4.04 | +0.24 | 0.17 |
| Meeting with legislators is a worthwhile use of my time. | 3.74 | 4.40 | +0.66 | 0.007 |
| It is part of my role as a physician-in-training to advocate for populations' health needs within society. | 4.10 | 4.54 | +0.44 | 0.04 |
| I feel that my role as a health advocate extends beyond the individual patient(s) I am treating. | 4.24 | 4.70 | +0.46 | 0.03 |
| I plan to engage in health legislative advocacy activities in the future. | 3.88 | 4.52 | +0.64 | 0.006 |
| | | | | |
| After participating in Advocacy Day, I feel more prepared to be a physician-advocate. | n/a | 4.30 | n/a | n/a |
| Participating in Advocacy Day has increased my commitment to engaging in health advocacy activities. | n/a | 4.37 | n/a | n/a |
| I am more likely to encourage others to engage in health advocacy activities as a result of my participation in Advocacy Day. | n/a | 4.46 | n/a | n/a |
*Participants were asked to react to the following statements using a 5-point Likert scale with 1 being “Strongly disagree” and 5 being “Strongly agree”
†These statements were included only on the post-survey.
Figure 1Responses to “I plan to engage in health legislative activities in the future”. Chart showing the number of responses received for each Likert score value (1 = Strongly Disagree to 5 = Strongly Agree) on pre- and post-advocacy surveys in response to the statement, “I plan to engage in health legislative activities in the future.” The mean Likert value increased from 3.88 to 4.52 (a change of 0.64) (p < 0.006) between pre- and post-advocacy surveys.